IQV
US EQUITY
Health Care
Life Sciences Tools & Services
CIK: 1478242
IQVIA (IQV) Quant Factor Diagnostic & Fair Value Model
IQVIA (Ticker: IQV) is listed in the Health Care sector (Life Sciences Tools & Services). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$279.36
+0.37%
Latest Close (2026-10-23)
Market Cap: $44.09B
P/E Ratio: 43.4
Momentum Strength
3M / 12M
+31.02%
1M: +1.58%
12M: +28.23%
Quality (ROE)
Point-in-Time
+17.26%
Trailing Return on Equity
Technical Trend
RSI 14
65.6
SMA50: $263.22
SMA200: $208.73
Valuation Multiplier
Trailing
43.4
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
IQV trades at 43.4x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 9/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1478242 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-03-31 | 2026-05-05 | - | $274.00M | $618.00M | $1.61 |
| 10-Q | 2025-12-31 | 2026-05-05 | - | - | - | - |
| 10-Q | 2025-03-31 | 2026-05-05 | - | $249.00M | $568.00M | $1.40 |
| 10-K | 2025-12-31 | 2026-02-17 | - | $1.36B | $2.65B | $7.84 |
| 10-K | 2024-12-31 | 2026-02-17 | - | $1.37B | $2.72B | $7.49 |
| 10-K | 2023-12-31 | 2026-02-17 | - | $1.36B | $2.15B | $7.29 |
| 10-Q | 2025-09-30 | 2025-10-28 | - | $331.00M | $1.92B | $1.93 |
| 10-Q | 2024-12-31 | 2025-10-28 | - | - | - | - |
💡 Methodology & Frequently Asked Questions
Key reference details regarding IQVIA (IQV) valuation multiples, momentum factors, and point-in-time filing conventions.
How should IQV's current valuation multiple be interpreted? ↓
IQV trades at a trailing P/E of 43.4x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are IQV's key momentum and technical factor indicators? ↓
As of the latest close, IQV shows a 1-month return of +1.58%, 3-month return of +31.02%, and 12-month return of +28.23%, with a 14-day RSI of 65.6. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for IQV? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can IQV be incorporated into systematic factor models? ↓
IQV can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.